Toward a prostate cancer precision medicine

被引:8
|
作者
Rubin, Mark A. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Weill Cornell Med Coll, Inst Precis Med, New York, NY 10065 USA
[2] New York Presbyterian Hosp, New York, NY USA
[3] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA
[4] Weill Cornell Med Coll, Dept Urol, New York, NY USA
[5] Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY USA
关键词
Prostate cancer; Precision medicine; Biomarkers; Next generation sequencing;
D O I
10.1016/j.urolonc.2014.10.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The promise of precision cancer medicine is that we will be able to pair clinical and genomic data to provide better and more efficient treatment for cancer care. Although the focus is on the optimal pairing of existing Food and Drug Administration approved drugs with the patient's tumor, precision medicine should also help determine a patient's risk for disease progression. Precision medicine will hopefully also lead to improved molecular biomarkers. The specific needs for predictive biomarkers vary significantly based on cancer type. The chief aim for prostate cancer. biomarker development is to help distinguish indolent from aggressive disease. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:73 / 74
页数:2
相关论文
共 50 条
  • [1] Precision medicine in prostate cancer
    Fujita, Kazutoshi
    ANNALS OF ONCOLOGY, 2021, 32 : S276 - S276
  • [2] Precision medicine for prostate cancer
    Galazi, Myria
    Rodriguez-Vida, Alejo
    Ng, Tony
    Mason, Malcolm
    Chowdhury, Simon
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (11) : 1305 - 1315
  • [3] Precision Medicine in Prostate Cancer
    Sakamoto, Shinichi
    Nisiho, Kazuto
    Ichikawa, Tomohiko
    ANNALS OF ONCOLOGY, 2019, 30 : 34 - 34
  • [4] Precision medicine in prostate cancer
    Sakamoto, Shinichi
    Ando, Keisuke
    Maihulan, Maimaiti
    Nishio, Kazuto
    Ichikawa, Tomohiko
    CANCER SCIENCE, 2018, 109 : 785 - 785
  • [5] Genomics and lipidomics analysis of blood and urine toward prostate cancer precision medicine
    Inoue, Takahiro
    Li, Xin
    Sumiyoshi, Takayuki
    Nakayama, Kenji
    Mizuno, Kei
    Okasho, Kosuke
    Goto, Takayuki
    Akamatsu, Shusuke
    Ogawa, Osamu
    CANCER SCIENCE, 2018, 109 : 1221 - 1221
  • [6] Toward precision medicine of breast cancer
    Carels, Nicolas
    Spinasse, Lizania Borges
    Tilli, Tatiana Martins
    Tuszynski, Jack Adam
    THEORETICAL BIOLOGY AND MEDICAL MODELLING, 2016, 13
  • [7] Prioritizing precision medicine for prostate cancer
    Attard, G.
    Beltran, H.
    ANNALS OF ONCOLOGY, 2015, 26 (06) : 1041 - 1042
  • [8] Precision medicine in pharmacotherapy for prostate cancer
    Shiota, Masaki
    CANCER SCIENCE, 2023, 114 : 1539 - 1539
  • [9] Precision medicine applications in prostate cancer
    McCrea, Edel M.
    Lee, Daniel K.
    Sissung, Tristan M.
    Figg, William D.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [10] Prospecting for prostate cancer with precision medicine
    Hill, Michelle M.
    Gardiner, Robert A.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S865 - S867